Page 213 - 2019_09-HaematologicaMondo-web

Redox-dependent regulation of platelets
References
1. Chaudhari K, Hamad B, Syed BA. Antithrombotic drugs market. Nat Rev Drug Discov. 2014;13(8):571-572.
2. Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med (Berl). 2011;89(2):109-121.
3. Iuliano L, Colavita AR, Leo R, Pratico D, Violi F. Oxygen free radicals and platelet activation. Free Radic Biol Med. 1997;22(6):999-1006.
4. WattJ,EwartM-A,GreigFH,OldroydKG, Wadsworth RM, Kennedy S. The effect of reactive oxygen species on whole blood aggregation and the endothelial cell- platelet interaction in patients with coro- nary heart disease. Thromb Res. 2012;130(2):210-215.
5. FreedmanJE.Oxidativestressandplatelets. Arterioscler Thromb Vasc Biol. 2008;28(3):s11-16.
6. Ferroni P, Vazzana N, Riondino S, Cuccurullo C, Guadagni F, Davi G. Platelet function in health and disease: from molec- ular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal. 2012;17(10):1447-1485.
7. Krotz F, Sohn HY, Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol. 2004;24(11):1988-1996.
8. Chondrogianni N, Petropoulos I, Grimm S, et al. Protein damage, repair and proteoly- sis. Mol Aspects Med. 2014;35:1-71.
9. Violi F, Pignatelli P. Platelet NOX, a novel target for anti-thrombotic treatment. Thromb Haemost. 2014;111(5):817-823.
10. BartimocciaS,CarnevaleR,SanguigniV,et al. NOX 5 is expressed in platelets from patients with chronic granulomatous dis- ease. Thromb Haemost. 2016;116(1):198- 200.
11. Krotz F, Sohn HY, Gloe T, et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruit- ment. Blood. 2002;100(3):917-924.
12. Begonja AJ, Gambaryan S, Geiger J, et al. Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-inte- grin activation independent of the
NO/cGMP pathway. Blood. 2005; 106(8):2757-2760.
13. Delaney MK, Kim K, Estevez B, et al. Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis. Arterioscler Thromb Vasc Biol. 2016;36(5):846-854.
14. Vara D, Campanella M, Pula G. The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus for- mation in a GPVI-dependent manner. Br J Pharmacol. 2013;168(1):212-224.
15. Magwenzi S, Woodward C, Wraith KS, et al. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. Blood. 2015;125(17):2693-2703.
16. Dikalov SI, Harrison DG. Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid Redox Signal. 2014;20(2):372-382.
17. GriendlingKK,TouyzRM,ZweierJL,etal. Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox- Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association. Circ Res. 2016;119(5):e39-75.
18. Koltai K, Kesmarky G, Feher G, Tibold A,
Toth K. Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications. Int J Mol Sci. 2017;18(8):1803.
19. Davies MJ. Detection and characterisation of radicals using electron paramagnetic res- onance (EPR) spin trapping and related methods. Methods. 2016;109:21-30.
20. Hawkins CL, Davies MJ. Detection and characterisation of radicals in biological materials using EPR methodology. Biochim Biophys Acta. 2014;1840(2):708-721.
21. Bedard K, Whitehouse S, Jaquet V. Challenges, Progresses, and Promises for Developing Future NADPH Oxidase Therapeutics. Antioxid Redox Signal. 2015;23(5):355-357.
22. Diebold BA, Smith SM, Li Y, Lambeth JD. NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress. Antioxid Redox Signal. 2015;23(5):375-405.
23. Pudusseri A, Shameem R, Spyropoulos AC. A new paradigm shift in antithrombotic therapy. Front Pharmacol. 2013;4:133.
24. Wong PC, Seiffert D, Bird JE, et al. Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding. Sci Transl Med. 2017;9(371).
25. Pietraforte D, Vona R, Marchesi A, et al. Redox control of platelet functions in phys- iology and pathophysiology. Antioxid Redox Signal. 2014;21(1):177-193.
patients. Biochem Biophys Res Commun.
2005;333(3):794-802.
35. Furie B, Flaumenhaft R. Thiol isomerases in
thrombus formation. Circ Res. 2014;
114(7):1162-1173.
36. Jang JY, Min JH, Wang SB, et al. Resveratrol
inhibits collagen-induced platelet stimula- tion through suppressing NADPH oxidase and oxidative inactivation of SH2 domain- containing protein tyrosine phosphatase-2. Free Radic Biol Med. 2015;89:842-851.
37. Jang JY, Min JH, Chae YH, et al. Reactive oxygen species play a critical role in colla- gen-induced platelet activation via SHP-2 oxidation. Antioxid Redox Signal. 2014;20(16):2528-2540.
38. Mazharian A, Mori J, Wang YJ, et al. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function. Blood. 2013;121(20):4205-4220.
39. Wang SB, Jang JY, Chae YH, et al. Kaempferol suppresses collagen-induced platelet activation by inhibiting NADPH oxidase and protecting SHP-2 from oxida- tive inactivation. Free Radic Biol Med. 2015;83:41-53.
40. Walsh TG, Berndt MC, Carrim N, Cowman J, Kenny D, Metharom P. The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus forma- tion. Redox Biol. 2014;2:178-186.
41. Obermayer G, Afonyushkin T, Binder CJ. Oxidized low-density lipoprotein in inflammation-driven thrombosis. J Thromb Haemost. 2018;16(3):418-428.
42. Jaunmuktane Z, Mead S, Ellis M, et al. Evidence for human transmission of amy- loid-beta pathology and cerebral amyloid angiopathy. Nature. 2015;525(7568):247-
26. Ranayhossaini DJ, Rodriguez AI, Sahoo S,
et al. Selective recapitulation of conserved
and nonconserved regions of putative
NOXA1 protein activation domain confers isoform-specific inhibition of Nox1 oxidase
and attenuation of endothelial cell migra-
tion. J Biol Chem. 2013;288(51):36437-
36450. 250.
27. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res. 2001;89(5):408-414.
28. Csanyi G, Cifuentes-Pagano E, Al Ghouleh I, et al. Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radic Biol Med. 2011;51(6):1116-1125.
29. Valente AJ, Jamali AE, Epperson TK, Gamez MJ, Pearson DW, Clark RA. NOX1 NADPH oxidase regulation by the NOXA1 SH3 domain. Free Radic Biol Med. 2007;43(3):384-396.
30. Lopez JJ, Salido GM, Gomez-Arteta E, Rosado JA, Pariente JA. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost. 2007;5(6):1283-1291.
31. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F. Hydrogen peroxide is involved in collagen-induced platelet acti- vation. Blood. 1998;91(2):484-490.
32. Qiao J, Arthur JF, Gardiner EE, Andrews RK, Zeng L, Xu K. Regulation of platelet activation and thrombus formation by reactive oxygen species. Redox Biol. 2018;14:126-130.
33. Chlopicki S, Olszanecki R, Janiszewski M, Laurindo FRM, Panz T, Miedzobrodzki J. Functional Role of NADPH Oxidase in Activation of Platelets. Antioxid Redox Signal. 2004;6(4):691-698.
34. Redondo PC, Jardin I, Hernandez-Cruz JM, Pariente JA, Salido GM, Rosado JA. Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggrega- tion in platelets from type 2 diabetic
43. Donner L, Falker K, Gremer L, et al. Platelets contribute to amyloid-beta aggre- gation in cerebral vessels through integrin alphaIIbbeta3-induced outside-in signaling and clusterin release. Sci Signal. 2016; 9(429):ra52.
44. Blair TA, Moore SF, Hers I. Circulating primers enhance platelet function and induce resistance to antiplatelet therapy. J Thromb Haemost. 2015;13(8):1479-1493.
45. Gresele P, Falcinelli E, Momi S. Potentiation and priming of platelet activation: a poten- tial target for antiplatelet therapy. Trends Pharmacol Sci. 2008;29(7):352-60.
46. Carnevale R, Bartimoccia S, Nocella C, et al. LDL oxidation by platelets propagates platelet activation via an oxidative stress- mediated mechanism. Atherosclerosis. 2014;237(1):108-116.
47. Abubaker AA, Vara D, Eggleston I, Canobbio I, Pula G. A novel flow cytome- try assay using dihydroethidium as redox- sensitive probe reveals NADPH oxidase- dependent generation of superoxide anion in human platelets exposed to amyloid peptide beta. Platelets. 2017;5:1-9.
48. Dayal S, Wilson KM, Motto DG, Miller FJ Jr., Chauhan AK, Lentz SR. Hydrogen per- oxide promotes aging-related platelet hyperactivation and thrombosis. Circulation. 2013;127(12):1308-1316.
49. Herczenik E, Bouma B, Korporaal SJ, et al. Activation of human platelets by misfolded proteins. Arterioscler Thromb Vasc Biol. 2007;27(7):1657-1665.
50. McFadyen JD, Schaff M, Peter K. Current and future antiplatelet therapies: emphasis on preserving haemostasis. Nat Rev Cardiol. 2018;15(3):181-191.
haematologica | 2019; 104(9)
1891